Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase NA 2Phase 4 2Phase 2 1

Status

Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urinary Bladder Neoplasms 2Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Rocuronium 2Ofloxacin 2Mitomycin 25-aminolevulinic acid hexyl ester 2remimazolam 1penpulimab 1pembrolizumab 1mebeverine 1lornoxicam 1enfortumab vedotin 1disitamab vedotin 1Ultrasonography 1Trimethoprim, Sulfamethoxazole Drug Combination 1Tobacco Use Cessation Devices 1Tamsulosin 1Sugammadex 1Specimen Handling 1Psychiatric Rehabilitation 1Propofol 1Polymerase Chain Reaction 1Nitrofurantoin 1Neuromuscular Blockade 1Neuroleptanalgesia 1Nephroureterectomy 1Neostigmine 1Midazolam 1Metformin 1Mepivacaine 1Magnetic Resonance Spectroscopy 1Levofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Urinary Bladder Neoplasms × 5-aminolevulinic acid hexyl ester × Clear all
NCT06548438 2024-08-12

TUR_BLUE

A.O.U. Città della Salute e della Scienza

Phase 4 Not yet recruiting
300 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00785694 2015-04-24

Recurrence of Bladder Cancer After Transurethral Resection With Hexvix

GE Healthcare

Phase 4 Withdrawn
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡